Effect of a Latent Tuberculosis Infection Programme for Healthcare Workers in a Country with an Intermediate Tuberculosis Burden.

Interferon-gamma Release Tests Latent tuberculosis Tuberculin Test

Journal

The Journal of hospital infection
ISSN: 1532-2939
Titre abrégé: J Hosp Infect
Pays: England
ID NLM: 8007166

Informations de publication

Date de publication:
29 Nov 2023
Historique:
received: 31 08 2023
revised: 08 11 2023
accepted: 13 11 2023
medline: 2 12 2023
pubmed: 2 12 2023
entrez: 1 12 2023
Statut: aheadofprint

Résumé

Management of latent tuberculosis infection (LTBI) among healthcare workers (HCWs) is crucial for the prevention of nosocomial tuberculosis (TB) transmission. We aimed to determine the effect of an LTBI programme for HCWs in a tertiary care hospital in a country with an intermediate TB burden. In 2013, baseline LTBI screening was implemented for newly hired doctors and nurses, along with annual screening of HCWs in high-risk departments. HCWs with LTBI were also provided with treatment. Since 2017, all HCWs without an LTBI test result have been tested for LTBI. We assessed the annual incidence of active TB among HCWs between 2013 and 2020. Additionally, we evaluated the incidence of active TB among HCWs employed at the hospital in 2020, with a specific focus on those who had undergone LTBI tests between 2013 and 2018, considering their LTBI test results and treatment status. The incidence of active TB among HCWs significantly decreased between 2013 and 2020. The average risk reduction for pulmonary TB was 10.2% per year (95% CI, 1.0-19.0; p = 0.034). Among HCWs employed at the hospital in 2020, 4,354 individuals underwent LTBI tests between 2013 and 2018. Out of them, 927 (21.3%) tested positive. Nine (1.5%) out of 588 without LTBI treatment developed active TB. Among the 1,285 HCWs who underwent follow-up testing, 62 (4.8%) converted, and one (4.3%) out of the 23 without treatment developed active TB. None of those who received treatment were diagnosed with active TB. The LTBI programme significantly reduced the incidence of active TB in HCWs. LTBI screening and treatment should be implemented, particularly in countries with a high or intermediate TB burden.

Sections du résumé

BACKGROUND BACKGROUND
Management of latent tuberculosis infection (LTBI) among healthcare workers (HCWs) is crucial for the prevention of nosocomial tuberculosis (TB) transmission. We aimed to determine the effect of an LTBI programme for HCWs in a tertiary care hospital in a country with an intermediate TB burden.
METHODS METHODS
In 2013, baseline LTBI screening was implemented for newly hired doctors and nurses, along with annual screening of HCWs in high-risk departments. HCWs with LTBI were also provided with treatment. Since 2017, all HCWs without an LTBI test result have been tested for LTBI. We assessed the annual incidence of active TB among HCWs between 2013 and 2020. Additionally, we evaluated the incidence of active TB among HCWs employed at the hospital in 2020, with a specific focus on those who had undergone LTBI tests between 2013 and 2018, considering their LTBI test results and treatment status.
MEASUREMENT AND MAIN RESULTS RESULTS
The incidence of active TB among HCWs significantly decreased between 2013 and 2020. The average risk reduction for pulmonary TB was 10.2% per year (95% CI, 1.0-19.0; p = 0.034). Among HCWs employed at the hospital in 2020, 4,354 individuals underwent LTBI tests between 2013 and 2018. Out of them, 927 (21.3%) tested positive. Nine (1.5%) out of 588 without LTBI treatment developed active TB. Among the 1,285 HCWs who underwent follow-up testing, 62 (4.8%) converted, and one (4.3%) out of the 23 without treatment developed active TB. None of those who received treatment were diagnosed with active TB.
CONCLUSION CONCLUSIONS
The LTBI programme significantly reduced the incidence of active TB in HCWs. LTBI screening and treatment should be implemented, particularly in countries with a high or intermediate TB burden.

Identifiants

pubmed: 38040036
pii: S0195-6701(23)00382-1
doi: 10.1016/j.jhin.2023.11.009
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

Copyright © 2023. Published by Elsevier Ltd.

Auteurs

Sun Young Cho (SY)

Centre for Infection Prevention and Control, Samsung Medical Centre, Seoul, Korea; Division of Infectious Diseases, Department of Internal Medicine, Samsung Medical Centre, Sungkyunkwan University School of Medicine, Seoul, Korea.

Eliel Nham (E)

Division of Infectious Diseases, Department of Internal Medicine, Korea University College of Medicine, Seoul, Korea.

Doo Ryeon Chung (DR)

Centre for Infection Prevention and Control, Samsung Medical Centre, Seoul, Korea; Division of Infectious Diseases, Department of Internal Medicine, Samsung Medical Centre, Sungkyunkwan University School of Medicine, Seoul, Korea. Electronic address: iddrchung@gmail.com.

Jieun Kim (J)

Centre for Infection Prevention and Control, Samsung Medical Centre, Seoul, Korea.

Jongsuk Jeong (J)

Centre for Infection Prevention and Control, Samsung Medical Centre, Seoul, Korea.

Jae-Hoon Ko (JH)

Division of Infectious Diseases, Department of Internal Medicine, Samsung Medical Centre, Sungkyunkwan University School of Medicine, Seoul, Korea.

Kyungmin Huh (K)

Division of Infectious Diseases, Department of Internal Medicine, Samsung Medical Centre, Sungkyunkwan University School of Medicine, Seoul, Korea.

Cheol-In Kang (CI)

Division of Infectious Diseases, Department of Internal Medicine, Samsung Medical Centre, Sungkyunkwan University School of Medicine, Seoul, Korea.

Kyong Ran Peck (KR)

Division of Infectious Diseases, Department of Internal Medicine, Samsung Medical Centre, Sungkyunkwan University School of Medicine, Seoul, Korea.

Classifications MeSH